ESC Premium Access

Lost to follow-up in cardiovascular trials.

Congress Presentation

About the speaker

Associate Professor Victor L Serebruany

Johns Hopkins University of Baltimore, Baltimore (United States of America)
2 presentations
0 follower

3 more presentations in this session

Critical issues in endpoint definition.

Speaker: Professor J. Tijssen (Amsterdam, NL)


Can we avoid randomized clinical trials for new CV drugs? .

Speaker: Ms K. Pieper (London, GB)


Current controversies in clinical trial design - Panel discussion.


Access the full session

Current controversies in clinical trial design

Speakers: Associate Professor V. Serebruany, Professor J. Tijssen, Ms K. Pieper

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb